# DESCRIPTION

## STATEMENT OF GOVERNMENT INTEREST

- disclose government support

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND

- describe quorum sensing
- motivate QS potentiators as drugs

## SUMMARY OF THE INVENTION

- summarize invention

## DETAILED DESCRIPTION OF THE INVENTION

- identify QS-activating molecules
- describe LuxO inhibitors and their properties

### Materials and Methods

- describe bacterial strains and culture conditions
- outline screening for QS-activating molecules
- describe protein purification and ATPase assays
- outline DNA binding assays and other analytical methods

### Chemical Reactions.

- describe experimental conditions
- synthesize compounds

## Results

- identify QS-activating molecules in V. cholerae

### Investigation of the Targets of the QS Activating Compounds

- determine targets of Class 1 and Class 2 compounds

### Structure-Activity-Relationship of Class 2 Compounds

- explore structure-activity relationship of Class 2 compounds

### Class 2 Compounds Inhibit the LuxO ATPase Activity

- investigate inhibition of LuxO ATPase activity by Class 2 compounds

### A Genetic Screen to Identify LuxO Mutants Resistant to Compound 12

- identify LuxO mutants resistant to compound 12

### Broad Spectrum Activation of Vibrio QS

- test compounds 11 and 12 in other Vibrio species

### New Chemical Tools for Controlling Virulence in Vibrios

- test LuxO inhibitors in virulence assays

## Discussion Of Results

- discuss implications of QS-activating molecules
- discuss potential of LuxO inhibitors as anti-virulence agents

